Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Insight Molecular Diagnostics (IMDX) Income from Continuing Operations: 2015-2024

Historic Income from Continuing Operations for Insight Molecular Diagnostics (IMDX) over the last 10 years, with Dec 2024 value amounting to -$61.0 million.

  • Insight Molecular Diagnostics' Income from Continuing Operations rose 18.25% to -$11.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.3 million, marking a year-over-year decrease of 41.10%. This contributed to the annual value of -$61.0 million for FY2024, which is 142.84% down from last year.
  • Per Insight Molecular Diagnostics' latest filing, its Income from Continuing Operations stood at -$61.0 million for FY2024, which was down 142.84% from -$25.1 million recorded in FY2023.
  • In the past 5 years, Insight Molecular Diagnostics' Income from Continuing Operations ranged from a high of -$10.5 million in FY2022 and a low of -$61.0 million during FY2024.
  • For the 3-year period, Insight Molecular Diagnostics' Income from Continuing Operations averaged around -$32.2 million, with its median value being -$25.1 million (2023).
  • Per our database at Business Quant, Insight Molecular Diagnostics' Income from Continuing Operations skyrocketed by 75.87% in 2022 and then slumped by 142.84% in 2024.
  • Over the past 5 years, Insight Molecular Diagnostics' Income from Continuing Operations (Yearly) stood at -$29.9 million in 2020, then plummeted by 45.79% to -$43.6 million in 2021, then surged by 75.87% to -$10.5 million in 2022, then plummeted by 139.12% to -$25.1 million in 2023, then crashed by 142.84% to -$61.0 million in 2024.